Bernstein Raises PT on CVS Health (CVS) to $91, Reiterates ‘Market Perform’ Rating

CVS Health Corporation (NYSE:CVS) is one of the most undervalued blue chip stocks to buy now. On January 6, 2026, Bernstein ...
Nasdaq

CVS Crosses Above Average Analyst Target

In recent trading, shares of CVS Health Corporation (Symbol: CVS) have crossed above the average analyst 12-month target price of $64.64, changing hands for $66.37/share. When a stock reaches the ...
Insider Monkey

CVS Health Corporation (CVS) Sees Higher Price Target Despite PBM Pressures

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein SocGen Group lifted the price target on CVS Health Corporation (NYSE:CVS) to ...